Commonwealth Consolidated Acts

[Index] [Table] [Search] [Search this Act] [Notes] [Noteup] [Previous] [Next] [Download] [Help]

NATIONAL HEALTH ACT 1953 - SECT 99ACD

First new brand price reductions for brands of combination items

When section applies to new brands

  (1)   Subject to subsections   (1A), (2) and (3), this section applies to a brand (the new brand ) of a pharmaceutical item (the trigger combination item ) that is a combination item if:

  (a)   a determination under subsection   85(6) comes into force in relation to the new brand of the trigger combination item on a day (the determination day ); and

  (b)   on the day before the determination day, the new brand of the trigger combination item was not a listed brand of the trigger combination item; and

  (c)   on the day before the determination day:

  (i)   a brand (the existing brand ) of a pharmaceutical item (the existing item ) was a listed brand of the existing item; and

  (ii)   the new brand of the trigger combination item is bioequivalent or biosimilar to the existing brand of the existing item; and

  (iii)   the drug in the trigger combination item and existing item contain the same component drugs; and

  (iv)   the trigger combination item and the existing item have the same manner of administration.

Note:   For the purposes of paragraph   (c), the new brand and the existing brand may be the same brand, or the trigger combination item and the existing item may be the same pharmaceutical item.

Circumstances in which section does not apply to new brands

  (1A)   This section does not apply in relation to the new brand of the trigger combination item if:

  (a)   the trigger combination item is in a class of pharmaceutical items to which a 12.5%, 16% or 25% administrative price reduction has applied; or

  (b)   another combination item that has the same drug and manner of administration as the new brand of the trigger combination item is in a class of pharmaceutical items to which a 12.5%, 16% or 25% administrative price reduction has applied; or

  (c)   if the drug in the trigger combination item is in a therapeutic group--a combination item that:

  (i)   has another drug that is in that group; and

  (ii)   has the same manner of administration as the new brand of the trigger combination item;

    is in a class of pharmaceutical items to which a 12.5%, 16% or 25% administrative price reduction has applied; or

  (d)   on the day before the determination day:

  (i)   the approved ex - manufacturer price of a listed brand of the existing item on 1   January 2016; or

  (ii)   if subparagraph   (i) does not apply--the original approved ex - manufacturer price of the first listed brand of the existing item;

    has, by virtue of previous price reductions, been reduced by 60% or more.

  (1B)   If the approved ex - manufacturer price mentioned in subparagraph   (1A)(d)(i) or (ii) is by reference to a different pricing quantity than the pricing quantity on the day before the determination day, the approved ex - manufacturer price mentioned in that subparagraph is taken to be the amount that the approved ex - manufacturer price would have been had the pricing quantity been the same as the pricing quantity on the day before the determination day.

  (2)   This section does not apply in relation to the new brand of the trigger combination item if a listed provision (see subsection   (2A)) has applied in relation to:

  (a)   the new brand, or another listed brand, of the trigger combination item; or

  (b)   a brand of another combination item that:

  (i)   has a drug that contains the same component drugs as the new brand of the trigger combination item; and

  (ii)   has the same manner of administration as the new brand of the trigger combination item; or

  (c)   if the drug in the trigger combination item is in a therapeutic group--a combination item that:

  (i)   has another drug that is in that group; and

  (ii)   has the same manner of administration as the new brand of the trigger combination item.

Note:   For the purposes of this subsection, subsections   (5) and (5A) of this section are taken not to have applied in relation to a brand of a pharmaceutical item in some cases: see section   99AEI and subsection   (7B) of this section.

  (2A)   For the purposes of subsection   (2), listed provision means:

  (a)   subsection   (5) or (5A); or

  (b)   a determination under paragraph   (7A)(b); or

  (c)   subsection   99ACF(1) or (2) because of item   4A, 4B or 8 in the table in subsection   99ACF(1); or

  (d)   section   99ACQ; or

  (e)   subsection   99ACR(3) or (4); or

  (f)   repealed section   99ACE.

  (3)   This section does not apply in relation to the new brand of the trigger combination item if:

  (a)   all of the following apply:

  (i)   the new brand of the trigger combination item is a new presentation of an existing listed brand of a pharmaceutical item;

  (ii)   a declaration under subsection   85(2) is in force in relation to the drug in the pharmaceutical item;

  (iii)   the determination day in relation to the new brand of the trigger combination item is on or before the fifth anniversary of the declaration under subsection   85(2) being made;

  (iv)   the responsible person for the new brand of the trigger combination item is the same as the responsible person for the existing listed brand of the pharmaceutical item;

  (v)   the drug is not on F2; or

  (b)   all of the following apply:

  (i)   the new brand of the trigger combination item is a new presentation of an existing listed brand of a pharmaceutical item;

  (ii)   the Minister has made a determination under section   99ACEA in relation to the new brand of the trigger combination item;

  (iii)   the determination under section   99ACEA has not ceased to have effect.

First new brand price reduction

  (4)   The Minister:

  (a)   may, under a price agreement, agree an agreed price for the new brand of the trigger combination item that comes into force on the determination day; and

  (b)   must not make a determination under section   85B for the new brand of the trigger combination item.

  (4A)   If, on the day before the determination day:

  (a)   the approved ex - manufacturer price of a listed brand of the existing item on 1   January 2016; or

  (b)   if paragraph   (a) does not apply--the original approved ex - manufacturer price of the first listed brand of the existing item;

has, by virtue of previous price reductions, been reduced by:

  (c)   35% or less, subsection   (5) applies; and

  (d)   more than 35% but less than 60%, subsection   (5A) applies.

Note:   If previous price reductions have been 60% or more, see paragraph   (1A)(d).

  (4B)   If the approved ex - manufacturer price mentioned in paragraph   (4A)(a) or (b) is by reference to a different pricing quantity than the pricing quantity on the day before the determination day, the approved ex - manufacturer price mentioned in that paragraph is taken to be the amount that the approved ex - manufacturer price would have been had the pricing quantity been the same as the pricing quantity on the day before the determination day.

  (5)   Subject to subsections   (7) and (7A), the agreed price of the new brand of the trigger combination item that comes into force on the determination day must not exceed the approved ex - manufacturer price, on the day before the determination day, of the existing brand of the existing item, reduced by 25%.

  (5A)   Subject to subsections   (7) and (7A), the agreed price of the new brand of the trigger combination item that comes into force on the determination day must not exceed:

  (a)   40% of the approved ex - manufacturer price of a listed brand of the existing item on 1   January 2016; or

  (b)   if paragraph   (a) does not apply--40% of the original approved ex - manufacturer price of the first listed brand of the existing item.

  (5B)   If the approved ex - manufacturer price mentioned in paragraph   (5A)(a) or (b) is by reference to a different pricing quantity than the pricing quantity on the day before the determination day, the approved ex - manufacturer price mentioned in that paragraph is taken to be the amount that the approved ex - manufacturer price would have been had the pricing quantity been the same as the pricing quantity on the day before the determination day.

Apportioning if pricing quantity changes

  (7)   If the pricing quantity of the existing brand of the existing item on the day before the determination day is different from the pricing quantity of the existing brand of the existing item on the determination day, then, for the purposes of subsections   (5) and (5A), the approved ex - manufacturer price of the existing brand of the existing item on the day before the determination day is taken to be the amount worked out as follows:

    Start formula start fraction AEMP1 over PQ1 end fraction times PQ2 end formula

where:

"AEMP1" means the amount that was the approved ex - manufacturer price of the existing brand of the existing item on the day before the determination day.

"PQ1" means the pricing quantity of the existing brand of the existing item on the day before the determination day.

"PQ2" means the pricing quantity of the existing brand of the existing item on the determination day.

Ministerial discretion not to apply, or to reduce, statutory price reduction

  (7A)   The Minister may, by notifiable instrument, determine that:

  (a)   the agreed price of the new brand of the trigger combination item that comes into force on the determination day is to be equal to the approved ex - manufacturer price, on the day before the determination day, of the existing brand of the existing item; or

  (b)   the agreed price of the new brand of the trigger combination item that comes into force on the determination day must not exceed the approved ex - manufacturer price, on the day before the determination day, of the existing brand of the existing item, reduced by a lower percentage than would otherwise result from the operation of subsection   (5) or (5A) in relation to the determination day.

  (7B)   If the Minister makes a determination under paragraph   (7A)(a), subsections   (5) and (5A) are taken not to have applied to the trigger combination item.

  (7C)   In making a determination under subsection   (7A):

  (a)   the Minister must take into account what the agreed price of the new brand of the trigger combination item would otherwise be under this section in relation to the particular determination day if a determination were not made; and

  (b)   the Minister may take into account any other matter that the Minister considers relevant.

Section does not limit Minister's powers

  (8)   This section does not limit the Minister's powers, after the determination day, to make:

  (a)   further price agreements; or

  (b)   determinations under section   85B;

for the new brand of the trigger combination item.


AustLII: Copyright Policy | Disclaimers | Privacy Policy | Feedback